Evaluation of the TAP-Preschool (TAP-P) for Tele-assessment of Autism in Preschool-aged Children
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07932665. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
TELE-ASD-PEDS-Preschool (TAP-P) Psychometrics and Decision Support for Preschool Autism Tele-Assessment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Use of tele-assessment for evaluation and diagnosis of autism in toddlers has demonstrated success in increasing service access and reducing clinical wait times, with high levels of diagnostic accuracy, clinician confidence, and family satisfaction; however, these models have not yet been rigorously evaluated within the preschool age range. The TAP-Preschool (TAP-P) was developed by the investigative team for tele-assessment of autism in preschool-aged children, with preliminary studies demonstrating utility with many children with limited verbal language and some children with more flexible verbal language. The proposed study will recruit a larger sample of children with varied language and phenotypic profiles to (1) thoroughly evaluate the psychometric properties of the TAP-P and (2) investigate child and family factors associated with diagnostic ascertainment and family satisfaction with tele-assessment to inform the creation of a decision support tool intended to recommend families for either tele- or in-person assessment, with the ultimate goal of optimizing clinical care models to serve patients in efficient ways while routing families to diagnostic care pathways that best fit their needs.
Study identification
- NCT ID
- NCT07932665
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 36 Months to 72 Months
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 4, 2026 (Actual)
- Primary completion
- Apr 30, 2031 (Estimated)
- Completion
- Apr 30, 2031 (Estimated)
- Last update posted
- Nov 12, 2026
2026 – 2031
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37212 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07932665, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 12, 2026 · Synced Nov 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.